Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Matthew Costa and Dr David Metcalfe have both been awarded Hunterian Professorships for 2020 by the Royal College of Surgeons of England

Named after the pioneering surgeon and scientist John Hunter and dating back over two centuries, the Hunterian Professorship is among the most highly-regarded annual awards in the field of surgery.

Matthew Costa, Professor of Orthopaedic Trauma Surgery has been awarded the Hunterian Professorship for his work on clinical trials and health economics.

Matt joined the University of Oxford in 2015 from the University of Warwick. His research interest is in clinical and cost effectiveness of musculoskeletal interventions and he is Chief Investigator for a series of randomised trials and associated studies. Cited widely, his work informs many guidelines from the National Institute for Health and Care Excellence (NICE).

Matt will deliver his Hunterian lecture entitled 'Changing Clinical Practice: latest evidence for clinical and cost-effectiveness in Trauma and Orthopaedic Surgery' at the British Orthopaedic Association (BOA) Congress in September.

David Metcalfe, Clinical Lecturer in Emergency Medicine, was also awarded a 2020 Hunterian Professorship for his work using routinely collected health data.

David was formerly a Fulbright Scholar at Harvard's Center for Surgery and Public Health and an Oxford-UCB Prize Fellow at the University of Oxford. His research interests lie in national clinical audit, health policy evaluation, evidence synthesis, and clinical risk prediction.

David's Hunterian lecture ('Improving hip fracture outcomes using routinely collected health data') builds on his DPhil, which was awarded the AOUK&I Trauma Research Prize and the Syme Medal of the Royal College of Surgeons of Edinburgh last year. His lecture will also be delivered at the BOA Congress in September.

Similar stories

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.